Source:http://linkedlifedata.com/resource/pubmed/id/17369141
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2007-3-19
|
pubmed:abstractText |
Although the pathogenesis of primary central nervous system lymphoma (PCNSL) remains unclear, it is hypothesized that specific chemokine-chemokine receptor interactions may attract malignant B lymphocytes into the CNS. Formalin-fixed, paraffin-embedded brain biopsy specimens from 40 patients with PCNSL were immunostained by an indirect immunohistochemical method incorporating antigen retrieval to detect the presence of B-cell chemokines, stromal cell-derived factor-1 (SDF-1; CXCL12) and macrophage inflammatory protein-3alpha (MIP-3alpha, CCL20), and the SDF-1 receptor, CXCR4. To assist in phenotyping of SDF-1 + cells, specimens were also stained for CD20 (B cells). Positive staining for SDF-1 was identified in all PCNSL cases and in tonsil. In biopsy specimens, SDF-1 expression was localized to resident brain cells and, in 80% of specimens, CD20+ malignant lymphocytes. Tumor cells also stained positively for CXCR4. In contrast, although expression ofMIP-3alpha was detected in tonsil, no expression of this chemokine could be demonstrated in PCNSL biopsy specimens. Our observations raise the possibility of targeting the SDF-1-CXCR4 signaling pathway as a potential treatment for PCNSL.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/CCL20 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/CXCL12 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CCL20,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CXCL12,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokines, CC,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokines, CXC,
http://linkedlifedata.com/resource/pubmed/chemical/Macrophage Inflammatory Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, CXCR4
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0002-9173
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
127
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
633-41
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:17369141-Adult,
pubmed-meshheading:17369141-Aged,
pubmed-meshheading:17369141-Aged, 80 and over,
pubmed-meshheading:17369141-B-Lymphocytes,
pubmed-meshheading:17369141-Brain Neoplasms,
pubmed-meshheading:17369141-Chemokine CCL20,
pubmed-meshheading:17369141-Chemokine CXCL12,
pubmed-meshheading:17369141-Chemokines, CC,
pubmed-meshheading:17369141-Chemokines, CXC,
pubmed-meshheading:17369141-Female,
pubmed-meshheading:17369141-Humans,
pubmed-meshheading:17369141-Immunohistochemistry,
pubmed-meshheading:17369141-Lymphoma, B-Cell,
pubmed-meshheading:17369141-Macrophage Inflammatory Proteins,
pubmed-meshheading:17369141-Male,
pubmed-meshheading:17369141-Middle Aged,
pubmed-meshheading:17369141-Receptors, CXCR4
|
pubmed:year |
2007
|
pubmed:articleTitle |
Malignant B cells from patients with primary central nervous system lymphoma express stromal cell-derived factor-1.
|
pubmed:affiliation |
Casey Eye Institute, Science University, Portland, OR 97239, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|